# Oxygen Treatment and Pulmonary Arterial Hypertension

> **NCT03683082** · NA · UNKNOWN · sponsor: **George Papanicolaou Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** Oxygen supplementation
- **DRUG:** Sham O2 (medical air)

## Key facts

- **NCT ID:** NCT03683082
- **Lead sponsor:** George Papanicolaou Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-05
- **Primary completion:** 2019-06-10
- **Final completion:** 2019-06-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2018-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03683082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03683082, "Oxygen Treatment and Pulmonary Arterial Hypertension". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03683082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*